Figure 1 from PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives. | Semantic Scholar
Frontiers | Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors | Oncology
Use of PARP inhibitors in ovarian cancer | Cancer World Archive
Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance | Bentham Science
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells: Trends in Cell Biology
PARP inhibitor - Wikipedia
PARP inhibitors: Treating mCRPC from a genetic basis
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance | Experimental & Molecular Medicine
PARP inhibitor resistance: the underlying mechanisms and clinical implications | Molecular Cancer | Full Text
JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers | HTML
PARP Inhibition | PARP Inhibitor Review
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
Resurrection of PARP Inhibitors in Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 9 (2018)
Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology
PARP inhibitors: Synthetic lethality in the clinic
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
Effects of pharmacologic PARP inhibition in B16F10 melanoma cells.... | Download Scientific Diagram
PARP inhibitors in cancer treatment | OncologyPRO
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future Directions | SpringerLink
PARP inhibitors in ovarian cancer - Cancer Treatment Reviews
